Triple-negative breast cancer (TNBC) cells lack the expression of the estrogen receptor (ER), progestin receptor (PR), and human epidermal growth factor receptor 2(HER2), which account for 15% to 20% of all newly diagnosed BC cases. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.